This study exploits policy reforms in Swedish primary care to examine the effect of pay-for-performance (P4P) on compliance with hypertension drug guidelines among public and private health care providers. Using provider-level outcome data for 2005–2013 from the Swedish Prescription Register, providers in regions using P4P were compared to providers in other regions in a difference-in-differences analysis. The results indicate that P4P improved guideline compliance regarding prescription of angiotensin converting enzyme inhibitors and angiotensin receptor blockers. The effect was mainly driven by private providers, suggesting that policy makers should take ownership into account when designing incentives for health care providers.

中文翻译：

---

瑞典公立和私立初级保健提供者按绩效付费对高血压药物处方的影响。

本研究利用瑞典初级保健的政策改革来研究按绩效付费（P4P）对公共和私人医疗保健提供者遵守高血压药物指南的影响。使用瑞典处方登记册 2005-2013 年提供者层面的结果数据，使用 P4P 地区的提供者与其他地区的提供者进行双重差异分析进行比较。结果表明，P4P 提高了血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂处方的指南依从性。这种影响主要是由私人提供者推动的，这表明政策制定者在设计医疗保健提供者的激励措施时应考虑所有权。